Affluent Medical S.A.
AFME.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | – | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -86% | 523% | 4.3% | – |
| Gross Profit | -€0 | -€0 | -€0 | -€0 |
| % Margin | -197.9% | -80.2% | -66.6% | -96.7% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -1,404.9% | -125.7% | -1,250.5% | -1,095.4% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -1,624.3% | -130.4% | -1,417.2% | -1,210.3% |
| EPS Diluted | -0.24 | -0.14 | -0.29 | -0.25 |
| % Growth | -71.4% | 51.7% | -16% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | -€0 |
| Capital Expenditures | -€0 | €0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | -€0 | -€0 |